Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

BUY
$0.26 - $0.64 $78 - $192
300 Added 42.86%
1,000 $0
Q2 2021

Aug 02, 2021

SELL
$1.04 - $1.5 $1,040 - $1,500
-1,000 Reduced 58.82%
700 $1,000
Q1 2021

Apr 29, 2021

SELL
$0.84 - $2.16 $2,016 - $5,184
-2,400 Reduced 58.54%
1,700 $2,000
Q4 2020

Jan 21, 2021

BUY
$0.65 - $1.11 $1,040 - $1,776
1,600 Added 64.0%
4,100 $4,000
Q3 2020

Oct 20, 2020

BUY
$0.48 - $0.84 $1,200 - $2,100
2,500 New
2,500 $2,000

Others Institutions Holding NMTR

About 9 METERS BIOPHARMA, INC.


  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.